Document is current
Any future updates will be listed below
-
Authors
,
Marquié, Marta
Valero, Sergi
Castilla-Marti, Miguel
Martínez, Joan
Rodríguez-Gómez, Octavio
Sanabria, Ángela
Tartari, Juan Pablo
Monté-Rubio, Gemma C.
Sotolongo-Grau, Oscar
Alegret, Montserrat
Pérez-Cordón, Alba
Roberto, Natalia
de Rojas, Itziar
Moreno-Grau, Sonia
Montrreal, Laura
Hernández, Isabel
Rosende-Roca, Maitee
Mauleón, Ana
Vargas, Liliana
Abdelnour, Carla
Gil, Silvia
Esteban-De Antonio, Ester
Espinosa, Ana
Ortega, Gemma
Lomeña, Francisco
Pavia, Javier
Vivas, Assumpta
Tejero, Miguel Ángel
Gómez-Chiari, Marta
Simó, Rafael
Ciudin, Andreea
Hernández, Cristina
Orellana, Adelina
Benaque, Alba
Ruiz, Agustín
Tárraga, Lluís
Boada, Mercè
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (796706)
European Foundation for the Study of Diabetes - ESFS/Lilly Mental Health and Diabetes 2013 Programme
Grifols
Life Molecular Imaging (N/A)
Araclon Biotech (N/A)
Fundació ACE Institut Català de Neurociències Aplicades (N/A)
Alkahest (N/A)
Laboratorio de análisis Echevarne (N/A)
IrsiCaixa (N/A)
- License Information
-
More Information
Article History
Received: 13 August 2019
Accepted: 20 March 2020
First Online: 31 March 2020
Ethics approval and consent to participate
: A written consent was obtained from all participants prior to the enrolment in the study. The FACEHBI protocol received approval from the ethics committees of Hospital Clínic i Provincial in Barcelona, Spain (EudraCT number 2014-00079-38). The referral centre ethics committee approved the patient recruitment, and collection protocols were in accordance with ethical standards according to World Medical Association Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects.
: Not applicable.
: MB has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai and Servier. She received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche and Servier. She has not received personal compensations from these organizations. The rest of the authors declare that they have no competing interests.
